Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Archives:
News
Astellas’
Qvents
May 15, 2023
FDA Releases Two Discussion Papers to Sp
Qvents
May 11, 2023
USFDA has issued a new
Qvents
May 11, 2023
MedinCell along with Teva gets approval
Qvents
May 4, 2023
Laurus Labs receives in-principle approv
Qvents
May 4, 2023
Teva USA is recalling thirteen lots of F
Qvents
April 30, 2023
Sun Pharma, Halol is recalling one lot o
Qvents Team
April 30, 2023
Akorn USA Issues recall of various Human
Qvents
April 29, 2023
Sun Pharma has received a USFDA Consent
Qvents
April 28, 2023
USFDAÂ had declined to approve Eli Lill
Qvents
April 18, 2023
1
…
25
26
27
28
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA 483 to Pharmathen Flags Deficient Aseptic Operations
February 5, 2026
Imprimis Recall Unapproved Ophthalmic Injections for Glass Particulates in US
January 5, 2026
Qvents Apps and Tools For QMS and GMP Processes
November 26, 2025
Laboratory Incidents and Validation Failures Lead to USFDA Warning Letter for Cdymax
November 25, 2025
Hetero USFDA Form 483: Unregistered Testing Lab, Undocumented Warehouse
October 18, 2025